CRISPR-Cas9–based target validation for p53-reactivating model compounds
Michael Wanzel(Universities of Giessen and Marburg Lung Center), Jonas B. Vischedyk(Philipps University of Marburg), Miriam P. Gittler(Philipps University of Marburg), Niklas Gremke(Philipps University of Marburg), Julia R. Seiz(Philipps University of Marburg), Mirjam Hefter(Philipps University of Marburg), Magdalena Noack(Philipps University of Marburg), Rajkumar Savai(German Center for Lung Research), Marco Mernberger(Philipps University of Marburg), Joël P. Charles(Philipps University of Marburg), Jean Schneikert(Philipps University of Marburg), Anne Catherine Bretz(Philipps University of Marburg), Andrea Nist(Philipps University of Marburg), Thorsten Stiewe(Universities of Giessen and Marburg Lung Center)
Cited by 92Open Access